por
Jatoi, Aminah,
Martenson, James,
Mahoney, Michelle R,
Lair, Bradley S,
Brindle, Jeffrey S,
Nichols, Frank,
Caron, Normand,
Rowland, Kendrith,
Tschetter, Loren,
Alberts, Steven
Publicado 2004
“…PURPOSE: An aggressive trimodality approach from the
Minnie Pearl Cancer Research Network [carboplatin AUC = 6, days 1 and 22; 5-fluorouracil 225 mg/m2 continuous infusion, days 1–42, paclitaxel 200 mg/m2, days 1 and 22; 45 Gy] has resulted in remarkable pathologic response rates but notable toxicity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto